Advertisement
Research summary
Research summary
04/16/2024

Jessica Ganga

Jessica Ganga
A team of researchers investigated the use of coconut water as an adjunct therapy for patients with mild-to-moderate ulcerative colitis.
04/16/2024
Research Summary
Research Summary
03/30/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers compared the health outcomes of adult patients with moderate ulcerative colitis and early advanced therapy initiation with those who delayed their advanced treatment initiation.
03/30/2024
FDA Alert
FDA Alert
03/21/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved resmetirom for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis with moderate-to-advanced liver fibrosis.
03/21/2024
Research Summary
Research Summary
03/13/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
03/13/2024
FDA Alert
FDA Alert
03/04/2024

Anthony Calabro, MA

Anthony Calabro, MA
The FDA approved irinotecan liposome with oxaliplatin, fluorouracil, and leucovorin as a first-line regimen for the management of patients with metastatic pancreatic adenocarcinoma.
03/04/2024
Research Summary
Research Summary
02/27/2024

Jessica Ganga

Jessica Ganga
Researchers with the American Gastroenterological Association (AGA) release a comprehensive set of guidelines on the use of biomarkers for monitoring and managing Crohn disease in patients.
02/27/2024
Research Summary
Research Summary
10/27/2023

Jessica Ganga

Jessica Ganga
The American College of Physicians have released an updated set of guidelines addressing when and how clinicians should screen for colorectal cancer in patients.
10/27/2023
FDA Alert
FDA Alert
06/15/2023

Jessica Ganga

Jessica Ganga
The FDA approved the first treatment for pediatric patients who experience functional constipation
06/15/2023
FDA Alert
FDA Alert
06/01/2023

Jessica Ganga

Jessica Ganga
The FDA has approved the first orally administered treatment for the gut infection—clostridioides difficile.
06/01/2023
FDA alert
FDA alert
05/25/2023

Jessica Ganga

Jessica Ganga
After clinical trials to assess the safety, efficacy, and maintenance use, the FDA has approved the first oral treatment for moderately to severely active Crohn disease.
05/25/2023